Insights in ILD Logo
Contact Us
  • ILD Overview
    • Interstitial Lung Disease
    • Evaluating Patients for Potential ILD
  • Connective Tissue Disease - ILDs
    • Connective Tissue Disease - ILDs
    • Rheumatoid Arthritis-related ILD
    • Sjogren's-related ILD
    • Systemic Lupus Erythematosus-related ILD
    • Polymyositis, Dermatomyositis, and Antisynthetase Syndrome
    • Polymyositis/Dermatomyositis-related ILD
    • Antisynthetase Syndrome-related ILD
    • Mixed Connective Tissue Disease-related ILD
    • Systemic Sclerosis-related ILD
    • Interstitial Pneumonia with Autoimmune Features
  • Sarcoidosis
  • Idiopathic ILD
    • Idiopathic Interstitial Pneumonias
    • Idiopathic Pulmonary Fibrosis
    • Idiopathic Nonspecific Interstitial Pneumonia
    • Respiratory Bronchiolitis--Associated Interstitial Lung Disease
    • Desquamative Interstitial Pneumonia
    • Cryptogenic Organizing Pneumonia
    • Acute Interstitial Pneumonia
    • Idiopathic Lymphoid Interstitial Pneumonia
    • Idiopathic Pleuroparenchymal Fibroelastosis
    • Unclassifiable Interstitial Pneumonia
  • Hypersensitivity Pneumonitis
  • Other ILD
    • Other ILD
    • Lymphangioleiomyomatosis (LAM)
    • Pulmonary Langerhans Cell Histiocytosis (LCH)
    • Exposure-related ILD
    • Drug-associated ILD
    • Occupational ILD
    • Vasculitis/Diffuse Alveolar Hemorrhage
    • Other Rare ILDs
    • Eosinophilic Pneumonia
    • Neurofibromatosis
  • ILD Overview
    • Interstitial Lung Disease
    • Evaluating Patients for Potential ILD
  • Connective Tissue Disease - ILDs
    • Connective Tissue Disease - ILDs
    • Rheumatoid Arthritis-related ILD
    • Sjogren's-related ILD
    • Systemic Lupus Erythematosus-related ILD
    • Polymyositis, Dermatomyositis, and Antisynthetase Syndrome
    • Polymyositis/Dermatomyositis-related ILD
    • Antisynthetase Syndrome-related ILD
    • Mixed Connective Tissue Disease-related ILD
    • Systemic Sclerosis-related ILD
    • Interstitial Pneumonia with Autoimmune Features
  • Sarcoidosis
  • Idiopathic ILD
    • Idiopathic Interstitial Pneumonias
    • Idiopathic Pulmonary Fibrosis
    • Idiopathic Nonspecific Interstitial Pneumonia
    • Respiratory Bronchiolitis--Associated Interstitial Lung Disease
    • Desquamative Interstitial Pneumonia
    • Cryptogenic Organizing Pneumonia
    • Acute Interstitial Pneumonia
    • Idiopathic Lymphoid Interstitial Pneumonia
    • Idiopathic Pleuroparenchymal Fibroelastosis
    • Unclassifiable Interstitial Pneumonia
  • Hypersensitivity Pneumonitis
  • Other ILD
    • Other ILD
    • Lymphangioleiomyomatosis (LAM)
    • Pulmonary Langerhans Cell Histiocytosis (LCH)
    • Exposure-related ILD
    • Drug-associated ILD
    • Occupational ILD
    • Vasculitis/Diffuse Alveolar Hemorrhage
    • Other Rare ILDs
    • Eosinophilic Pneumonia
    • Neurofibromatosis
  • Case Studies
    • Case 1: 52 year old Male
    • Case 2: 67 year old Male
    • Case 3: 40 year old Female
    • Case 4: 72 year old Male
  • Expert Videos
    • Recognizing Autoimmune Interstitial Lung Diseases
      Expert Faculty: Chase Correia, MD, Northwestern Medicine; Felipe Martinez, MD, Cleveland Clinic
    • SSc-ILD: When Systemic Sclerosis Affects the Lung
      Expert Faculty: Joy Schechtman, DO, Banner Health
    • Interstitial Lung Diseases: An Overview of Progression and Radiological Features
      Expert Faculty: Gregory Cosgrove, MD, FCCP, National Jewish Health; Jonathan Chung, MD, The University of Chicago Medicine
    • Recognizing Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype
      Expert Faculty: Ayodeji Adegunsoye, MD, FACP, FCCCP, The University of Chicago Medicine
    • What is Fibrosis? It’s More Than Just UIP
      Expert Faculty: Ayodeji Adegunsoye, MD, FACP, FCCCP; Jonathan H. Chung, MD
    • Diagnosing Interstitial Lung Disease: Perspectives on Current Challenges in Emerging Technologies
      Expert Faculty: Michael C. Zlupko, MD; Jonathan G. Goldin, MD, PhD; Lida P. Hariri, MD, PhD
    • Fibrotic Lung Diseases: Features and Patterns to Aid in Differential Diagnosis
      Expert Faculty: David Lynch, MB, BCH
  • Podcasts
    • How to Recognize Chronic Fibrosing ILD with a Progressive Phenotype and the Power of New Technology in Genetic Profiling of ILD Subsets
      Expert Faculty: Kristin Highland, MD, Cleveland Clinic; Rebecca Keith, MD, National Jewish Health
    • What Good Looks Like in HRCT: Specific Parameters That are Critical for Identifying ILDs on HRCT Scans
      Expert Faculty: Ayodeji Adegunsoye, MD, FACP, FCCCP, The University of Chicago Medicine; Jonathan Chung, MD, The University of Chicago Medicine
    • What Good Looks Like: Recognition & Nonpharmacological Management of ILDs
      Expert Faculty: Amy Olson, MD, MSPH (Moderator), National Jewish Health; Mark Hamblin, MD, University of Kansas Medical Center; Cedric Jamie Rutland, MD, Rutland Medical Group (West Coast Lung); Chase Hall, MD, University of Kansas Medical Center
    • Women in ILD: Managing ILD Patients During the COVID Pandemic
      Expert Faculty: Cori Fratelli, RN
    • Live from ATS: Commonalities Among the Interstitial Lung Diseases
      Expert Faculty: Erica Herzog, MD, PhD; Steven D. Nathan, MD
    • Live from ACR: A Conversation on Systemic Sclerosis-Associated Interstitial Lung Disease
      Expert Faculty: Richard M Silver, MD; Lorinda Chung, MD, MS
    • Live from A collection of three conversations between a leading pulmonologist and rheumatologist that covers the recognition, diagnosis, and management of patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).
      Expert Faculty: Aryeh Fischer, MD; Jeffrey Swigris, DO, MS
  • New & Views
  • Privacy Notice
  • Terms of Use
  • Contact Us
  • Site Map

Copyright 2021, Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Policy.     12/21     PC‑US‑124311

Boehringer Ingelheim Logo

You’re leaving this website

You are now leaving a Boehringer Ingelheim Pharmaceuticals, Inc. site. Boehringer Ingelheim Pharmaceuticals, Inc. has not reviewed the contents of all pages and sites that may be linked to this site. Boehringer Ingelheim Pharmaceuticals, Inc. is not responsible and disclaims any liability for the content of any other page or site or for any viruses or similar harmful programs that may be present on such pages or sites. Linking to any other page or site is at your own risk.

Continue    Stay on this site